ArticleBMJ open2026

FOLFOX-based transarterial infusion chemotherapy for unresectable colorectal cancer: protocol of an open-label, multicentre, randomised, controlled, phase II trial.

Junpeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.